Novacell Technology develops novel biomarker that may accurately diagnose breast cancer

Published: 2013-08-22 06:57:00
Updated: 2013-08-22 06:57:00
Novacell Technology said yesterday it has created a new biomarker NCB102 that is considered to a highly accurate method of obtaining a preoperative histological diagnosis of breast cancer showing a resistance to Roche’s Herceptin.

Recently, the company conducted a clinical test in a local univ...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.